Event Recap: Exploring the Frontiers in Heart Failure


The tenth installment of the 2026 Asian Cardiovascular Disease Series of Web Seminars concluded successfully on November 17, 2026, from 19:00 to 20:30 Beijing Time (12:00–13:30 CET). Centered on the theme "Dialogue Between Chinese and Foreign Experts – Frontiers in Heart Failure," this virtual gathering united leading experts from China and Italy for a highly productive academic exchange.

Presided over by Prof. Xinli Li (CN), the proceedings commenced with his introductory remarks. The program then featured two distinguished lectures: Prof. Stefania Paolillo (IT) presented on "New Classification and Novelties of HF Treatment: From Drugs to Interventional Therapy," while Prof. Wenyan Wang (CN) explored "Focusing on the New Concept of HF Guidelines, Discuss the Benefits of Using β-Blockers in Different Comorbidities."

A dynamic panel session, guided by Prof. Mulei Chen (CN) and Prof. Huanji Zhang (CN), fostered an in-depth dialogue on the evolving clinical positioning of beta-blockers within the "four pillars" era, individualized titration strategies, and the identification of specific patient populations most likely to benefit. The event wrapped up with a comprehensive summary from Prof. Xinli Li (CN), encapsulating the essential takeaways from this international collaboration.

Click here to review the full session replay. We remain dedicated to sharing actionable clinical knowledge and advancing cardiovascular care across Asia.